These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 34899137)
1. Escitalopram-induced epistaxis: A case report. AlJhani SA J Taibah Univ Med Sci; 2021 Dec; 16(6):938-942. PubMed ID: 34899137 [TBL] [Abstract][Full Text] [Related]
2. Selective Serotonin Reuptake Inhibitors and Associated Bleeding Risks: A Narrative and Clinical Review. Edinoff AN; Raveendran K; Colon MA; Thomas BH; Trettin KA; Hunt GW; Kaye AM; Cornett EM; Kaye AD Health Psychol Res; 2022; 10(4):39580. PubMed ID: 36425234 [TBL] [Abstract][Full Text] [Related]
3. Feeling blue to seeing red: A case of escitalopram-induced epistaxis. Ogundare T; Ologun OA Clin Case Rep; 2024 Jul; 12(7):e9128. PubMed ID: 38983874 [TBL] [Abstract][Full Text] [Related]
4. An emerging role for escitalopram in the treatment of obsessive-compulsive disorder. Hedges DW; Woon FL Neuropsychiatr Dis Treat; 2007 Aug; 3(4):455-61. PubMed ID: 19300574 [TBL] [Abstract][Full Text] [Related]
5. The role of selective serotonin reuptake inhibitors in preventing relapse of major depressive disorder. Clevenger SS; Malhotra D; Dang J; Vanle B; IsHak WW Ther Adv Psychopharmacol; 2018 Jan; 8(1):49-58. PubMed ID: 29344343 [TBL] [Abstract][Full Text] [Related]
6. Anxiety and depression: individual entities or two sides of the same coin? Nutt D Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():19-24. PubMed ID: 24930685 [TBL] [Abstract][Full Text] [Related]
8. New treatment options for OCD. Fineberg NA Int J Psychiatry Clin Pract; 2007; 11 Suppl 2():24-30. PubMed ID: 24926869 [TBL] [Abstract][Full Text] [Related]
9. Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data. Solem CT; Shelbaya A; Wan Y; Deshpande CG; Alvir J; Pappadopulos E Neuropsychiatr Dis Treat; 2016; 12():2755-2764. PubMed ID: 27822048 [TBL] [Abstract][Full Text] [Related]
13. [Ecchymosis associated with the use of fluoxetine: case report]. Mirsal H; Kalyoncu A; Pektaş O Turk Psikiyatri Derg; 2002; 13(4):320-4. PubMed ID: 12794649 [TBL] [Abstract][Full Text] [Related]
14. Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability. Kirino E Patient Prefer Adherence; 2012; 6():853-61. PubMed ID: 23271894 [TBL] [Abstract][Full Text] [Related]
15. Paroxetine: an update of its use in psychiatric disorders in adults. Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL Drugs; 2002; 62(4):655-703. PubMed ID: 11893234 [TBL] [Abstract][Full Text] [Related]
16. Rabbit Syndrome Likely Induced by Escitalopram: A Case Report. Nimber JS; Aggarwal A J Pharm Technol; 2014 Oct; 30(5):179-181. PubMed ID: 34860880 [No Abstract] [Full Text] [Related]
17. The importance of serotonin and noradrenaline in anxiety. Blier P; El Mansari M Int J Psychiatry Clin Pract; 2007; 11 Suppl 2():16-23. PubMed ID: 24926868 [TBL] [Abstract][Full Text] [Related]
18. Escitalopram for the treatment of major depression and anxiety disorders. Höschl C; Svestka J Expert Rev Neurother; 2008 Apr; 8(4):537-52. PubMed ID: 18416657 [TBL] [Abstract][Full Text] [Related]
19. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder. Foster RH; Goa KL CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224 [TBL] [Abstract][Full Text] [Related]